published meta-analysis   sensitivity analysis   studies

Renin-angiotensin-system-acting agents in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsLopes (BRACE CORONA), 2021 0.97 [0.38; 2.50] REPLACE, 2020 0.87 [0.35; 2.18] 0.92[0.47; 1.77]Lopes (BRACE CORONA), 2021, REPLACE, 202020%811lownot evaluable mechanical ventilationdetailed resultsLopes (BRACE CORONA), 2021 1.25 [0.76; 2.06] 1.25[0.76; 2.06]Lopes (BRACE CORONA), 202110%659NAnot evaluable ICU admissiondetailed resultsREPLACE, 2020 0.82 [0.37; 1.82] 0.82[0.37; 1.82]REPLACE, 202010%152NAnot evaluable0.52.01.0relative treatment effectwww.metaEvidence.org2024-05-08 06:01 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 612,552,590,891,605,892,722,618,609 - roots T: 290